Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on March 12, 2009

Arteriosclerosis, Thrombosis, and Vascular Biology. 2009
Published online before print March 12, 2009, doi: 10.1161/ATVBAHA.109.185694
A more recent version of this article appeared on June 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
29/6/889    most recent
ATVBAHA.109.185694v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orimo, M.
Right arrow Articles by Komuro, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orimo, M.
Right arrow Articles by Komuro, I.

Submitted on February 3, 2009
Accepted on March 3, 2009

Protective Role of SIRT1 in Diabetic Vascular Dysfunction

Masayuki Orimo ; Tohru Minamino ; Hideyuki Miyauchi ; Kaoru Tateno ; Sho Okada ; Junji Moriya ; and Issei Komuro *

From the Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Japan.

* To whom correspondence should be addressed. E-mail: komuro-tky{at}umin.ac.jp.

Objective—Calorie restriction (CR) prolongs the lifespan of various species, ranging from yeasts to mice. In yeast, CR extends the lifespan by increasing the activity of silencing information regulator 2 (Sir2), an NAD+-dependent deacetylase. SIRT1, a mammalian homolog of Sir2, has been reported to downregulate p53 activity and thereby prolong the lifespan of cells. Although recent evidence suggests a link between SIRT1 activity and metabolic homeostasis during CR, its pathological role in human disease is not yet fully understood.

Methods and Results—Treatment of human endothelial cells with high glucose decreases SIRT1 expression and thus activates p53 by increasing its acetylation. This in turn accelerates endothelial senescence and induces functional abnormalities. Introduction of SIRT1 or disruption of p53 inhibits high glucose–induced endothelial senescence and dysfunction. Likewise, activation of Sirt1 prevents the hyperglycemia-induced vascular cell senescence and thereby protects against vascular dysfunction in mice with diabetes.

Conclusions—These findings represent a novel mechanism of vascular cell senescence induced by hyperglycemia and suggest a protective role of SIRT1 in the pathogenesis of diabetic vasculopathy.


Key words: cellular senescence • p53 • diabetes